Treatment News : No Improvement in Survival of HIV-Related Lymphoma

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 30, 2013

No Improvement in Survival of HIV-Related Lymphoma

Mortality rates for those diagnosed with HIV-related lymphoma have remained flat during the modern era of antiretrovirals (ARVs), HealthDay reports. Publishing their findings in the Journal of the National Cancer Institute, researchers analyzed data from 476 HIV-positive American study participants with various forms of HIV-related lymphoma between 1996 and 2010. The lymphoma types included non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, diffuse large B-cell lymphoma, Burkitt’s lymphoma and primary central nervous system lymphoma.

Lymphoma is the most frequent cause of cancer-related deaths among people with HIV.

Those diagnosed with lymphoma in more recent years were more likely to be male, Latino and gay, to have experienced an AIDS-related illness and to be on ARVs, with higher CD4 levels and better viral suppression.

Being diagnosed more recently did not translate into an improved chance at survival. Also, those who developed lymphoma while taking ARVs had a doubled mortality rate. Researchers theorize that this may be an effect of biologic differences in tumors that develop in the presence of ARVs as compared with their absence; more research is needed on this topic.

To read a release on the study, click here.

To read the HealthDay report, click here.

Search: HIV-related lymphoma, HealthDay, Hodgkin’s lymphoma, Hodgkin’s lymphoma, diffuse large B-cell lymphoma, Burkitt’s lymphoma, primary central nervous system lymphoma, mortality rates.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.